通过降低GluA1酸化,抑制神经素2可以缓解发作
Mengnan Xing1, Xinlei Yang2, Sinan Jin3
1Department of Pediatrics, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Cell biochemistry and function
|April 10, 2024
概括
神经质素2 (Nptx2) 在中被上调. 在小鼠中降低Nptx2水平减少了发作,脑损伤和亡,改善了记忆力,表明Nptx2是潜在的治疗.
科学领域:
- 神经科学是一个神经科学.
- 的研究研究.
- 突触性可塑性 突触性可塑性
背景情况:
- 神经素2 (Nptx2) 是一种突触蛋白,涉及激发性突触形成.
- 在模型中,Nptx2被上调,但其具体作用尚不清楚.
研究的目的:
- 为了研究Nptx2在中的作用.
- 为了确定Nptx2是否是的可行的治疗标.
主要方法:
- 已建立的卡因酸诱导的小鼠模型和体外性泄漏模型.
- 使用了Nptx2敲击,脑电图记录,行为测试和各种染色技术 (Nissl,Timms,免疫光).
- 分析了亡标记物 (Bax,分裂的卡斯帕酶3/9,Bcl-2) 和突触蛋白表达 (GluA1,PSD95).
主要成果:
- Nptx2 Knockdown 降低了发作频率,持续时间和电脑图幅度.
- 沉默Nptx2缓解了引起的脑损伤,降低了神经元亡,改善了学习和记忆.
- Nptx2的淘汰影响了GluA1的酸化和膜表达,并使PSD95水平正常化.
结论:
- Nptx2在病的发病过程中起着重要作用.
- 通过减少神经元损伤和亡,Nptx2沉默为提供了一个有前途的治疗策略.
- 准Nptx2可能会改善与相关的认知缺陷.
相关概念视频
Antiepileptic Drugs: GABAergic Pathway Potentiators
388
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
388
Antiepileptic Drugs: Glutamate Antagonists
325
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
325
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
288
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
288
Antiepileptic Drugs: Potassium Channel Activators
176
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
176
Antiepileptic Drugs: Calcium Channel Blockers
382
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
382
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K


